13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001835943
Total reported value
$1.6B
$1.6B
37 檔
8.5%
The Q3 2025 SEC filing reveals that AIGH Capital Management LLC held a total portfolio value of $1.6B, covering 37 public equity positions.
AIGH Capital Management LLC executed strategic sector rebalancing during Q3 2025, establishing 16 new positions while fully exiting 19 holdings and trimming 8 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | STX | Seagate Technology Holdings plc | Stock-Tech | 10.69% | — | — | |
| 2 | SNDK | Sandisk CORP | Stock-Tech | 8.85% | +4.02% | — | |
| 3 | PSNL | Personalis Inc | Stock-Other | 7.15% | -1.07% | +4.52% | |
| 4 | DOMO | Domo Inc - Class B | Stock-Other | 5.99% | +0.57% | NEW | |
| 5 | ZVRA | Zevra Therapeutics Inc | Stock-Other | 5.46% | -1.53% | EXIT | |
| 6 | ARQ | Arq Inc | Stock-Other | 5.20% | — | -2.83% | |
| 7 | MXL | Maxlinear Inc | Stock-Other | 5.02% | +6.60% | NEW | |
| 8 | LASR | Nlight Inc | Stock-Other | 5.01% | -2.64% | EXIT | |
| 9 | CSTL | Castle Biosciences Inc | Stock-Other | 4.54% | -1.16% | — | |
| 10 | LUMN | Lumen Technologies Inc | Stock-Comm Services | 4.40% | — | — | |
| 11 | GLW | Corning Inc | Stock-Tech | 3.48% | — | +2088.26% | |
| 12 | MBLY | Mobileye Global Inc-a | Stock-Other | 3.19% | — | — | |
| 13 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 3.02% | — | — | |
| 14 | APPS | Digital Turbine Inc | Stock-Other | 2.75% | +3.40% | — | |
| 15 | BKTI | Bk Technologies CORP | Stock-Other | 2.36% | -0.33% | EXIT | |
| 16 | VPG | Vishay Precision Group | Stock-Other | 2.26% | — | -40.97% | |
| 17 | ESPR | Esperion Therapeutics Inc | Stock-Other | 2.24% | -1.64% | EXIT | |
| 18 | LPTH | Lightpath Technologies Inc-a | Stock-Other | 2.01% | -0.14% | EXIT | |
| 19 | FENC | Fennec Pharmaceuticals Inc | Stock-Other | 1.80% | +0.02% | +50.64% | |
| 20 | COYA | Coya Therapeutics Inc | Stock-Other | 1.78% | -0.29% | — | |
| 21 | VELO | Velo3d Inc | Stock-Other | 1.49% | — | — | |
| 22 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 1.42% | — | — | |
| 23 | AMBA | Ambarella, Inc. | Stock-Tech | 1.16% | — | — | |
| 24 | TLPH | Talphera Inc | Stock-Other | 1.12% | -0.17% | — | |
| 25 | ✓ | Polypid LTD | Stock-Other | 1.00% | -0.47% | -10.80% | |
| 26 | RNXT | Renovorx Inc | Stock-Other | 0.94% | -0.23% | -24.57% | |
| 27 | LRMR | Larimar Therapeutics Inc | Stock-Other | 0.91% | -1.84% | EXIT | |
| 28 | ELUT | Elutia Inc | Stock-Other | 0.79% | -0.34% | -8.28% | |
| 29 | VUZI | Vuzix CORP | Stock-Other | 0.79% | +0.19% | — | |
| 30 | GRCE | Grace Therapeutics Inc | Stock-Other | 0.76% | — | -19.61% | |
| 31 | IPWR | Ideal Power Inc | Stock-Other | 0.73% | -0.16% | -23.27% | |
| 32 | NRXS | Neuraxis Inc | Stock-Other | 0.35% | -0.16% | — | |
| 33 | ELVA | Electrovaya Inc | Stock-Other | 0.32% | — | -91.09% | |
| 34 | ARDX | Ardelyx Inc | Stock-Other | 0.31% | +1.03% | NEW | |
| 35 | BFRI | Biofrontera Inc | Stock-Other | 0.29% | -0.06% | +7.34% | |
| 36 | APRE | Aprea Therapeutics Inc | Stock-Other | 0.22% | -0.06% | — | |
| 37 | SMTK | Smartkem Inc | Stock-Other | 0.20% | -0.03% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DOMO | Domo Inc - Class B | +3.6% | — | Add |
| 2 | APPS | Digital Turbine Inc | +2.3% | — | Add |
| 3 | PSNL | Personalis Inc | +1.4% | +4.52% | Trim |
| 4 | ZVRA | Zevra Therapeutics Inc | +1% | +384.61% | Add |
| 5 | FENC | Fennec Pharmaceuticals Inc | +0.9% | +50.64% | Add |
| 6 | ARQ | Arq Inc | +0.4% | -2.83% | Trim |
| 7 | NRXS | Neuraxis Inc | +0.3% | — | Add |
| 8 | GLW | Corning Inc | +0.2% | +2088.26% | Add |
| 9 | ✓ | Polypid LTD | -0.1% | -10.80% | Add |
| 10 | VPG | Vishay Precision Group | -0.4% | -40.97% | Trim |
| 11 | IPWR | Ideal Power Inc | -1% | -23.27% | Trim |
| 12 | COYA | Coya Therapeutics Inc | -1.4% | — | Trim |
| 13 | ELVA | Electrovaya Inc | -1.9% | -91.09% | Trim |
| 14 | BKTI | Bk Technologies CORP | -2% | — | Trim |
| 15 | ELUT | Elutia Inc | -2.8% | -8.28% | Trim |
| 16 | STX | Seagate Technology Holdings plc | — | NEW | New buy |
| 17 | QQQ | Invesco Qqq Trust Series 1 | — | EXIT | Sold out |
| 18 | SNDK | Sandisk CORP | — | NEW | New buy |
| 19 | MXL | Maxlinear Inc | — | NEW | New buy |
| 20 | LASR | Nlight Inc | — | NEW | New buy |
| 21 | CSTL | Castle Biosciences Inc | — | NEW | New buy |
| 22 | LUMN | Lumen Technologies Inc | — | NEW | New buy |
| 23 | VSTM | Verastem Inc | — | EXIT | Sold out |
| 24 | MYO | Myomo Inc | — | EXIT | Sold out |
| 25 | MBLY | Mobileye Global Inc-a | — | NEW | New buy |
| 26 | SCPH | Scpharmaceuticals Inc | — | EXIT | Sold out |
| 27 | DAWNGBX | Day One Biopharmaceuticals I | — | NEW | New buy |
| 28 | BLZE | Backblaze Inc-a | — | EXIT | Sold out |
| 29 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
| 30 | ESPR | Esperion Therapeutics Inc | — | NEW | New buy |
| 31 | HRTX | Heron Therapeutics Inc | — | EXIT | Sold out |
| 32 | AKBA | Akebia Therapeutics Inc | — | EXIT | Sold out |
| 33 | VELO | Velo3d Inc | — | NEW | New buy |
| 34 | PHAT | Phathom Pharmaceuticals Inc | — | NEW | New buy |
| 35 | IDN | Intellicheck Inc | — | EXIT | Sold out |
| 36 | ANGO | Angiodynamics Inc | — | EXIT | Sold out |
| 37 | AMBA | Ambarella, Inc. | — | NEW | New buy |
| 38 | TLPH | Talphera Inc | — | NEW | New buy |
| 39 | DCTH | Delcath Systems Inc | — | EXIT | Sold out |
| 40 | TQ80 | Theratechnologies Inc | — | EXIT | Sold out |
| 41 | LRMR | Larimar Therapeutics Inc | — | NEW | New buy |
| 42 | VUZI | Vuzix CORP | — | NEW | New buy |
| 43 | ✓ | Biodesix Inc | — | EXIT | Sold out |
| 44 | FKWL | Franklin Wireless CORP | — | EXIT | Sold out |
| 45 | TELA | Tela Bio Inc | — | EXIT | Sold out |
| 46 | AMPG | Amplitech Group Inc | — | EXIT | Sold out |
| 47 | KALAEUR | Kala Bio Inc | — | EXIT | Sold out |
| 48 | ARDX | Ardelyx Inc | — | NEW | New buy |
| 49 | ✓ | — | EXIT | Sold out | |
| 50 | KPRX | Kiora Pharmaceuticals Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, AIGH Capital Management LLC reported a total U.S. public equity portfolio value of $1.6B across 37 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including STX, SNDK, PSNL) accounted for 8.5% of total reported equity market value during Q3 2025.
Top New Position Initiated
STX
市值: $37.9M
Top Position Liquidated / Trimmed
QQQ
前期市值: $32.8M
During Q3 2025, AIGH Capital Management LLC's top holdings by market value included STX (10.7%)、SNDK (8.8%)、PSNL (7.2%). The largest single position, STX, represented 10.7% of total portfolio value.
In Q3 2025, AIGH Capital Management LLC made 50 total portfolio adjustments, initiating 16 new buys, adding to 7 positions, trimming 8 holdings, and fully liquidating 19 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.